Heterodimerization of Bcl-2 and BcL-XL with Bax and Bad in colorectal cancer

被引：6
|
作者：
Hattori, T
Ookawa, N
Fujita, R
Fukuchi, K
机构：
[1] Showa Univ, Fujigaoka Hosp, Dept Gastroenterol, Aoba Ku, Yokohama, Kanagawa 2278501, Japan
[2] Showa Univ, Sch Med, Dept Clin Pathol, Shinagawa Ku, Tokyo 142, Japan
来源：
ACTA ONCOLOGICA | 2000年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The rate of cell loss owing to apoptosis is mediated by competitive dimerization with selective pairs of cell death antagonists (Bcl-2, BcL-X-L) and agonists (Bax, Bad). The aim of this study was to investigate which Bcl-2 family dimers had a critical factor in colorectal cancer. We analyzed the expression of Bcl-2, Bcl-X-L, Bax, and Bad in normal-appearinging mucosa and colorectal tumor tissues by Western blotting after immunoprecipitation. Compared with the ratio of Bax-Bcl-2/total Bax in normal mucosa, the ratio was significantly reduced in tumors (p = 0.02). In this series, the low ratio of Bad-Bcl-2/total Bcl-2 was associated with advanced tumor stages (p = 0.02). A reduced heterodimerization of Bax with Bcl-2 may contribute to the development of colorectal cancer. The heterodimerization of Bad with Bcl-2 may be repressed in advanced tumor tissues, and may contribute to tumor growth in colorectal cancer.
引用
收藏
页码：495 / 500
页数：6
相关论文
共 50 条
  • [1] The role of the C-terminal membrane anchor domain of Bcl-XL in heterodimerization of Bcl-XL and Bax
    Jeong, SY
    Hsu, YT
    Lee, YJ
    Sharpe, J
    Motoshi
    Suzuki
    Youle, RJ
    [J]. FASEB JOURNAL, 2003, 17 (05): : A1004 - A1005
  • [2] Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas
    Ogura, E
    Senzaki, H
    Yamamoto, D
    Yoshida, R
    Takada, H
    Hioki, K
    Tsubura, A
    [J]. ONCOLOGY REPORTS, 1999, 6 (02) : 365 - 369
  • [3] A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2
    Renault, Thibaud T.
    Dejean, Laurent M.
    Manon, Stephen
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2017, 161 : 201 - 210
  • [4] The expression of Bcl-2, bax, Bcl-xl and bad in the human term placenta after hypoxia and reoxygenation
    Hung, T. H.
    Hsieh, T. T.
    [J]. PLACENTA, 2006, 27 (9-10) : A26 - A26
  • [5] Mtd, a novel Bcl-2 family member activates apoptosis in the absence of heterodimerization with Bcl-2 and Bcl-XL
    Inohara, N
    Ekhterae, D
    Garcia, I
    Carrio, R
    Merino, J
    Merry, A
    Chen, S
    Núñez, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) : 8705 - 8710
  • [6] High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels:: Molecular predictors for survival of stage 2 soft tissue sarcoma patients
    Köhler, T
    Würl, P
    Meye, A
    Lautenschläger, C
    Bartel, F
    Borchert, S
    Bache, M
    Schmidt, H
    Holzhausen, HJ
    Taubert, H
    [J]. ANTICANCER RESEARCH, 2002, 22 (03) : 1553 - 1559
  • [7] Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas
    Gobé, G
    Rubin, M
    Williams, G
    Sawczuk, I
    Buttyan, R
    [J]. CANCER INVESTIGATION, 2002, 20 (03) : 324 - 332
  • [8] Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer
    Han, Hye Seung
    Park, Young-Mee
    Hwang, Tae Sook
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (07) : 1108 - 1114
  • [9] Expression of bcl-2, bax, bcl-xL, and bcl-xS, in endometrial and cervical tissues
    Mozzetti, S
    Ferrandina, G
    Marone, M
    D'Ingiullo, F
    Fruscella, E
    De Pasqua, A
    Mancuso, S
    Scambia, G
    [J]. CANCER DETECTION AND PREVENTION, 2000, 24 (06): : 536 - 541
  • [10] Bcl-2, Bax, Bcl-xL and Bcl-xS expression in neoplastic and normal endometrium
    Marone, M
    Ferrandina, G
    Macchia, G
    Mozzetti, S
    de Pasqua, A
    Benedetti-Panici, P
    Mancuso, S
    Scambia, G
    [J]. ONCOLOGY, 2000, 58 (02) : 161 - 168
12345